| Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress T Lammers, F Kiessling, WE Hennink, G Storm Journal of controlled release 161 (2), 175-187, 2012 | 1594 | 2012 |
| Tumor targeting via EPR: Strategies to enhance patient responses SK Golombek, JN May, B Theek, L Appold, N Drude, F Kiessling, ... Advanced drug delivery reviews 130, 17-38, 2018 | 1233 | 2018 |
| Smart cancer nanomedicine R van der Meel, E Sulheim, Y Shi, F Kiessling, WJM Mulder, T Lammers Nature nanotechnology 14 (11), 1007-1017, 2019 | 1100 | 2019 |
| Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications SM Dadfar, K Roemhild, NI Drude, S von Stillfried, R Knüchel, F Kiessling, ... Advanced drug delivery reviews 138, 302-325, 2019 | 1076 | 2019 |
| Theranostic nanomedicine T Lammers, S Aime, WE Hennink, G Storm, F Kiessling Accounts of chemical research 44 (10), 1029-1038, 2011 | 1048 | 2011 |
| MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 A Schober, M Nazari-Jahantigh, Y Wei, K Bidzhekov, F Gremse, ... Nature medicine 20 (4), 368-376, 2014 | 692 | 2014 |
| Vascular normalization in Rgs5-deficient tumours promotes immune destruction J Hamzah, M Jugold, F Kiessling, P Rigby, M Manzur, HH Marti, T Rabie, ... Nature 453 (7193), 410-414, 2008 | 642 | 2008 |
| MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages M Nazari-Jahantigh, Y Wei, H Noels, S Akhtar, Z Zhou, RR Koenen, ... The Journal of clinical investigation 122 (11), 4190-4202, 2012 | 596 | 2012 |
| Applications of nanoparticles for diagnosis and therapy of cancer SC Baetke, T Lammers, F Kiessling The British journal of radiology 88 (1054), 20150207, 2015 | 555 | 2015 |
| PLGA-based nanoparticles in cancer treatment S Rezvantalab, NI Drude, MK Moraveji, N Güvener, EK Koons, Y Shi, ... Frontiers in pharmacology 9, 1260, 2018 | 550 | 2018 |
| Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation M Talelli, M Barz, CJF Rijcken, F Kiessling, WE Hennink, T Lammers Nano today 10 (1), 93-117, 2015 | 545 | 2015 |
| Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects S Kunjachan, J Ehling, G Storm, F Kiessling, T Lammers Chemical reviews 115 (19), 10907-10937, 2015 | 500 | 2015 |
| Nanotheranostics and image-guided drug delivery: current concepts and future directions T Lammers, F Kiessling, WE Hennink, G Storm Molecular pharmaceutics 7 (6), 1899-1912, 2010 | 487 | 2010 |
| Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis A Abdollahi, M Li, G Ping, C Plathow, S Domhan, F Kiessling, LB Lee, ... Journal of experimental medicine 201 (6), 925-935, 2005 | 485 | 2005 |
| Super-resolution ultrasound imaging K Christensen-Jeffries, O Couture, PA Dayton, YC Eldar, K Hynynen, ... Ultrasound in medicine & biology 46 (4), 865-891, 2020 | 461 | 2020 |
| Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner C Zhang, M Jugold, EC Woenne, T Lammers, B Morgenstern, MM Mueller, ... Cancer research 67 (4), 1555-1562, 2007 | 461 | 2007 |
| Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications LY Rizzo, B Theek, G Storm, F Kiessling, T Lammers Current opinion in biotechnology 24 (6), 1159-1166, 2013 | 419 | 2013 |
| MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence Y Berker, J Franke, A Salomon, M Palmowski, HCW Donker, Y Temur, ... Journal of nuclear medicine 53 (5), 796-804, 2012 | 413 | 2012 |
| Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines S Kunjachan, R Pola, F Gremse, B Theek, J Ehling, D Moeckel, ... Nano letters 14 (2), 972-981, 2014 | 376 | 2014 |
| Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics F Kiessling, S Fokong, P Koczera, W Lederle, T Lammers Journal of nuclear medicine 53 (3), 345-348, 2012 | 372 | 2012 |
